Oncology

A look at dvm360®'s upcoming August CEs and events

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), highlights an innovative, effective method for treating mast cell tumors

Addresses need for better treatment options especially for large or giant breeds mostly affected by this cancer

Successful research may aid in developing diagnostic tools that can be key in early detection

Plan your educational goals with these upcoming continuing education events and learning opportunities

After finishing his final round of chemotherapy, the 210-pound rescue and his family celebrated by ringing the “BTHO Cancer” bell.

3 articles highlighting breakthrough data in the veterinary medicine world

Research findings display new treatment has potential to also advance human cancer care

Through a strategic relationship, PetDx is making OncoK9 immediately available to all Antech Diagnostics customers in the United States and Canada

Assessing traditional and recently approved therapies for canine lymphoma

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), explains why pet parents are often hesitant about chemotherapy for their dogs

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), outlined the innovative tools currently being used in practice to address canine cancer

During a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), offered her expert insight on detecting canine cancer early for the most successful outcomes

On National Canine Cancer Awareness Day, a canine cancer registry and cancer care index initiative was launched in New York City featuring experts and entertainers bringing attention to the latest dog oncology research and insights

The Take C.H.A.R.G.E. scientific advisory board of veterinary oncologists and experts support adoption of new comparative oncology diagnostic codes to strengthen the initiative’s impact

In light of the first National Canine Cancer Awareness Day, this initiative will launch in NYC and feature well-known veterinary cancer specialist speakers, plus Broadway performers

3 articles covering the ins and outs of cancer in companion animals

Vicki Pollard, CVT, AIA, explains how hospital design factors into the safety of handling hazardous drugs

Check out this week’s highlights on dvm360.com.

The importance of research on GI lymphoma and IBD and how to participate in the Basepaws study

Exploring the differences between traditional chemotherapy and targeted therapy

Marks 13th annual pet cancer campaign led by Petco Love in partnership with Blue Buffalo

Jaguar Animal Health’s crofelemer product has conditional approval from the FDA

The CANcer Detection in Dogs (CANDiD) study demonstrates the performance of the novel liquid biopsy OncoK9 and sets a new benchmark for veterinary medicine.

Craig A. Clifford, DVM, MS, DACVIM (Oncology), offered an overview of the latest treatment and diagnostic tools accelerating veterinary oncology

Learn key hospital design protocols to help protect patients and staff

Tumor cells and metabolites can be shed into the urine and these molecules may be used for tumor detection.

This marks the first study designed to examine pet exposure to aromatic amines in the household.

An experienced clinician discusses the road to success when the diagnostic path is unclear.

Investigators with pet health insurer Nationwide examined claims for 1.6 million dogs